SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 571 filers reported holding SEAGEN INC in Q1 2023. The put-call ratio across all filers is 2.46 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $100,760,218 | +35.8% | 474,948 | +23.2% | 0.03% | +42.1% |
| Q2 2023 | $74,194,869 | -66.5% | 385,508 | -64.8% | 0.02% | -69.4% |
| Q1 2023 | $221,526,072 | +40.4% | 1,094,118 | -10.9% | 0.06% | +34.8% |
| Q4 2022 | $157,828,400 | -15.1% | 1,228,141 | -9.7% | 0.05% | -23.3% |
| Q3 2022 | $185,998,000 | -21.4% | 1,359,342 | +1.6% | 0.06% | -16.7% |
| Q2 2022 | $236,623,000 | -2.0% | 1,337,308 | -20.2% | 0.07% | +16.1% |
| Q1 2022 | $241,386,000 | -6.0% | 1,675,718 | +0.9% | 0.06% | 0.0% |
| Q4 2021 | $256,852,000 | -4.6% | 1,661,402 | +4.7% | 0.06% | -8.8% |
| Q3 2021 | $269,344,000 | +75.8% | 1,586,239 | +63.5% | 0.07% | +78.9% |
| Q2 2021 | $153,193,000 | +8.5% | 970,314 | -4.6% | 0.04% | 0.0% |
| Q1 2021 | $141,166,000 | -23.3% | 1,016,603 | -3.3% | 0.04% | -29.6% |
| Q4 2020 | $184,047,000 | – | 1,050,847 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $8,300,656,000 | 47.09% |
| Eagle Health Investments LP | 262,502 | $46,447,000 | 10.83% |
| EcoR1 Capital, LLC | 1,008,628 | $178,467,000 | 6.16% |
| Lagoda Investment Management, L.P. | 49,460 | $8,751,000 | 5.80% |
| Redmile Group, LLC | 854,013 | $151,109,000 | 5.77% |
| Nan Fung Group Holdings Ltd | 47,096 | $8,333,000 | 5.72% |
| Atika Capital Management LLC | 282,500 | $49,985,000 | 5.62% |
| Avoro Capital Advisors LLC | 1,525,000 | $269,834,000 | 5.33% |
| Parkman Healthcare Partners LLC | 76,626 | $13,558,000 | 4.99% |
| Artal Group S.A. | 525,000 | $92,894,000 | 4.96% |